Market Tracker

05/26 8:59am ET

Orexigen Therapeutics Inc (NASDAQ:OREX)

2.94
Delayed Data
As of May 25
 +0.07 / +2.44%
Today’s Change
1.65
Today|||52-Week Range
6.49
+68.97%
Year-to-Date

Today’s Trading

Previous close2.87
Today’s open2.94
Day’s range2.85 - 2.94
Volume44,476
Average volume (3 months)368,406
Market cap$44.8M
Dividend yield--
Data as of 05/25/2017

Growth & Valuation

Earnings growth (last year)+67.69%
Earnings growth (this year)-495.83%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+37.82%
P/E ratioNM
Price/Sales0.75
Price/Book0.75

Competitors

 Today’s
change
Today’s
% change
CTRVContraVir Pharmaceut...-0.01-0.75%
GNMXAevi Genomic Medicin...-0.08-6.25%
OVASOvaScience Inc-0.01-0.76%
ITEKInotek Pharmaceutica...-0.05-2.78%
Data as of 05/25/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$2.40
Annual revenue (last year)$33.7M
Annual profit (last year)-$24.5M
Net profit margin-72.75%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Narachi
Chief Operating Officer &
Executive Vice President
Thomas R. Cannell
Corporate headquarters
La Jolla, California

Forecasts